Arvind Sood | VP of IR |
Bob Bradway | Chairman and CEO |
David Meline | CFO |
Murdo Gordon | Head of Global Commercial Operations |
David Reese | Head of R&D |
Matthew Harrison | Morgan Stanley |
Terence Flynn | Goldman Sachs |
Ying Huang | Bank of America-Merrill Lynch |
Geoffrey Porges | Leerink Partners |
Kennen Mackay | RBC Capital Markets |
Carter Gould | UBS Equities |
Yaron Werber | Cowen and Company |
Do Kim | BMO Capital Markets |
Jay Olson | Oppenheimer |
Michael Yee | Jefferies |
Alethia Young | Cantor Fitzgerald |
Cory Kasimov | JP Morgan |
Geoffrey Meacham | Barclays |
Umer Raffat | Evercore ISI |
Ronny Gal | Bernstein |
Salim Syed | Mizuho Securities |
My name is Ian and I will be your conference facilitator today for Amgen's First Quarter 2019 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the last speaker’s prepared remarks. In order to ensure that everyone has a chance to participate, we would like to request that you limit yourself to asking one question during the Q&A session. [Operator Instructions] I would now like to introduce Arvind Sood, Vice President of Investor Relations.